An open-label, randomized, single-dose, 4 period crossover relative bioavailability study comparing APC-5000 (fluticasone propionate and salmeterol xinafoate) and Advair Diskus
Latest Information Update: 05 Mar 2015
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
Most Recent Events
- 05 Mar 2015 New trial record